Duncan Richards

Has grant

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

NIHR Oxford CRF

Open Date: 2022-09-01

Close Date: 2027-09-01

Grant: Close

Helping alleviate the longer-term consequences of covid-19 (heal-covid): a national platform trial

Open Date: 2021-04-01

Close Date:

Grant: Close

AVID-CC Adalimumab for COVID19 in community care

Open Date: 2020-08-01

Close Date: 2021-09-30

Grant: Close

Novel therapies for covid19.

Open Date: 2020-04-01

Close Date: 2021-12-01

Grant: Close

In vitro characterization of effects of nanobubbles on joint tissue.

Open Date: 2020-03-01

Close Date: 2021-08-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (28)

Melissa Dobson

University of Oxford

UNITED KINGDOM

View details

Philip Evans

Professor of Primary Care Research

University of Exeter

UNITED KINGDOM

View details

Jienchi Dorward

Academic Clinical Lecturer

University of Oxford

UNITED KINGDOM

View details

Clare Calvert

University of Oxford

UNITED KINGDOM

View details

Emma Ogburn

University of Oxford

UNITED KINGDOM

View details

University of Oxford

UNITED KINGDOM

View details

UNITED KINGDOM

View details

Lucy Cureton

University of Oxford

UNITED KINGDOM

View details

Kerri Johannson

Associate Professor

University of Calgary

CANADA

View details

Roel De Maeyer

University of Oxford

UNITED KINGDOM

View details

Emanuela Falaschetti

Imperial College London

UNITED KINGDOM

View details

Helen Higham

Associate Professor

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Duncan Richards

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Developing generic clinical trial animated explainer videos in the UK: results of a survey and case study.

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration

REMOVED: Ivermectin and COVID-19.

Removal notice to "Ivermectin and COVID-19" Journal of Infection 91 (2025) 106530.

Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.

Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial

Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS‐CoV‐2

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC)

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study

COVID-19 therapeutics: Challenges and directions for the future

Corrigendum to ‘Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes’ [Surgery 171 (2021) 77–87] (Surgery (2022) 171(1) (77–87), (S0039606021004530), (10.1016/j.surg.2021.04.041))

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

Predictive validity in drug discovery: what it is, why it matters and how to improve it

Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes.

Collaborators (28)

Melissa Dobson

Philip Evans

Jienchi Dorward

Clare Calvert

Emma Ogburn

Oliver van Hecke

Greg Irving

Manuela Funke

VICTORIA HARRIS

Nigel D. Hart

Kate Lines

John Grainger

Duncan Appelbe

Andrew Carson-Stevens

Nicole Zitzmann

Alberta Ateere

Joseph Cheriyan

Lucy Cureton

Kerri Johannson

Roel De Maeyer

Emanuela Falaschetti

Helen Higham

Azhar Zafar

Julie Bertrand

Paul Little

Christopher Butler

Gail Hayward

James Fullerton

Make your next move.